日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Bispecific antibodies and CAR T cells targeting a TP53 mutation-associated neoantigen show discordant affinity requirements.

针对TP53突变相关新抗原的双特异性抗体和CAR T细胞表现出不一致的亲和力要求。

DiNapoli Sarah R, Wright Katharine M, Mog Brian J, Pearlman Alexander H, Nichakawade Tushar D, Marcou Nikita, Hsiue Emily Han-Chung, Hwang Michael S, Douglass Jacqueline, Liu Qiang, Watson Evangeline, Dal Molin Marco, Cohen Joshua D, Popoli Maria, Paul Suman, Konig Maximilian F, Wyhs Nicolas, Azurmendi P Aitana, Glavaris Stephanie, Ge Jiaxin, Awosika Tolulope O, Liu Jin, Gabrielson Kathleen L, Gabelli Sandra B, Pardoll Drew M, Bettegowda Chetan, Papadopoulos Nickolas, Kinzler Kenneth W, Zhou Shibin, Vogelstein Bert

Lethal toxin-equipped effector cells for the potential treatment of cancer

携带致命毒素的效应细胞可用于癌症的潜在治疗

Pearlman, Alexander H; Mog, Brian J; Hwang, Michael S; Rincon-Torroella, Jordina; DiNapoli, Sarah R; Paul, Suman; Douglass, Jacqueline; Hsiue, Emily Han-Chung; Glavaris, Stephanie A; Pardoll, Drew M; Papadopoulos, Nickolas; Kinzler, Kenneth W; Bettegowda, Chetan; Zhou, Shibin; Vogelstein, Bert; Konig, Maximilian F

TRBC2-targeting antibody-drug conjugates for the treatment of T cell cancers.

靶向 TRBC2 的抗体药物偶联物用于治疗 T 细胞癌。

Ge Jiaxin, Urban Joshua, DiNapoli Sarah R, Lee Bum Seok, Ahmedna Taha, Nichakawade Tushar D, Mog Brian J, Lu Steve, Li Xuyang, Marcou Nikita, Glavaris Stephanie, Douglass Jacqueline, Liu Jin, Konig Maximilian F, Watson Evangeline, Popoli Maria, Peske J David, Rozati Sima, Sterling Cole H, Wagner-Johnston Nina, Ambinder Richard F, Gabrielson Kathy, Mullighan Charles G, Papadopoulos Nickolas, Bettegowda Chetan, Pardoll Drew M, Zhou Shibin, Sur Surojit, Kinzler Kenneth W, Vogelstein Bert, Paul Suman

Six events that shaped antibody approvals in oncology

影响肿瘤抗体审批的六大事件

Paul, Suman; Zhou, Shibin

Risk factors for postoperative pneumonia following thoracoscopic lobectomy: a retrospective study with a focus on preoperative fasting duration

胸腔镜肺叶切除术后肺炎的危险因素:一项以术前禁食时间为重点的回顾性研究

Lin, Hongyan; Tang, Yun; Zhou, Shibin; Huang, Wei; Hu, Ling; Jin, Liang

Engineering immunotoxin-equipped effector cells and evaluation in primary human immune cells

构建携带免疫毒素的效应细胞并在原代人免疫细胞中进行评估

Pearlman, Alexander H; Mog, Brian J; Hwang, Michael S; Rincon-Torroella, Jordina; DiNapoli, Sarah R; Paul, Suman; Douglass, Jacqueline; Hsiue, Emily Han-Chung; Glavaris, Stephanie A; Pardoll, Drew M; Papadopoulos, Nickolas; Kinzler, Kenneth W; Bettegowda, Chetan; Zhou, Shibin; Vogelstein, Bert; Konig, Maximilian F

Precision targeting of autoreactive B cells in systemic lupus erythematosus using anti-9G4 idiotope synthetic immune receptor T cells.

利用抗9G4特异性合成免疫受体T细胞精确靶向系统性红斑狼疮中的自身反应性B细胞。

Liu Jin, Xia Yuanxuan, Mog Brian J, Gliech Colin, Shaw Elana, Ferris Dylan, Moritz Brock, Awosika Tolulope O, DiNapoli Sarah R, Glavaris Stephanie, Kaeo Kyle J, Li Xuyang, Marcou Nikita, Pearlman Alexander H, Ahmedna Taha S, Bugrovsky Regina, Sanz Iñaki, Bettegowda Chetan, Paul Suman, Alvarado Victoria Duarte, Wirtz Denis, Goldman Daniel, Petri Michelle, Kinzler Kenneth W, Zhou Shibin, Andrade Felipe, Vogelstein Bert, Konig Maximilian F

Cancer therapy with antibodies

利用抗体进行癌症治疗

Paul, Suman; Konig, Maximilian F; Pardoll, Drew M; Bettegowda, Chetan; Papadopoulos, Nickolas; Wright, Katharine M; Gabelli, Sandra B; Ho, Mitchell; van Elsas, Andrea; Zhou, Shibin

Preclinical studies show that Co-STARs combine the advantages of chimeric antigen and T cell receptors for the treatment of tumors with low antigen densities.

临床前研究表明,Co-STARs 结合了嵌合抗原和 T 细胞受体的优势,可用于治疗抗原密度低的肿瘤

Mog Brian J, Marcou Nikita, DiNapoli Sarah R, Pearlman Alexander H, Nichakawade Tushar D, Hwang Michael S, Douglass Jacqueline, Hsiue Emily Han-Chung, Glavaris Stephanie, Wright Katharine M, Konig Maximilian F, Paul Suman, Wyhs Nicolas, Ge Jiaxin, Miller Michelle S, Azurmendi P, Watson Evangeline, Pardoll Drew M, Gabelli Sandra B, Bettegowda Chetan, Papadopoulos Nickolas, Kinzler Kenneth W, Vogelstein Bert, Zhou Shibin

Targeting public neoantigens for cancer immunotherapy

靶向公共新抗原进行癌症免疫治疗

Pearlman, Alexander H; Hwang, Michael S; Konig, Maximilian F; Hsiue, Emily Han-Chung; Douglass, Jacqueline; DiNapoli, Sarah R; Mog, Brian J; Bettegowda, Chetan; Pardoll, Drew M; Gabelli, Sandra B; Papadopoulos, Nicholas; Kinzler, Kenneth W; Vogelstein, Bert; Zhou, Shibin